Regeneron Pharmaceuticals Inc is a
prestigious company university
established in 1988 in United States. It is represented
by 190 scientists in the AD Scientific Index. The
university’s scientists are particularly concentrated in
Medical and Health Sciences (69 scientists), Natural Sciences (53 scientists), and Engineering & Technology (4 scientists).
* Total H Index Rankings
Ranking Based
On Selection: 1
Respiratory drug development
clinical trials
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
69
51
0.739
* Total H Index Rankings
Ranking Based
On Selection: 2
Asthma
genetics
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
66
50
0.758
* Total H Index Rankings
Ranking Based
On Selection: 3
biotechnology
genetics
clinical trials
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
58
54
0.931
* Total H Index Rankings
Ranking Based
On Selection: 4
clinical pharmacology
monoclonal antibodies
drug-drug interactions
pharmacokinetics/pharmacodynamics
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
34
24
0.706
* Total H Index Rankings
Ranking Based
On Selection: 5
HEOR
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
33
22
0.667
* Total H Index Rankings
Ranking Based
On Selection: 6
Molecular Imaging
Antibody-based therapeutics
immunoPET
Targeted Radiotherapy
Cancer Biology
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
27
20
0.741
* Total H Index Rankings
Ranking Based
On Selection: 7
asthma
urticaria
pediatrics
nasal polyps
food allergy
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
26
23
0.885
* Total H Index Rankings
Ranking Based
On Selection: 8
Quantitative Clinical Pharmacology
Clinical Pharmacometrics
Statistics
Drug Development
Clinical
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
25
18
0.720
* Total H Index Rankings
Ranking Based
On Selection: 9
Biotherapeutic Protein/AAV Characterization
LC-MS/MS
Bottom-Up Proteomics
Target Proteomics
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
23
16
0.696
* Total H Index Rankings
Ranking Based
On Selection: 10
Anti-cancer antibodies and cancer immunotherapy
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
23
15
0.652
* Total H Index Rankings
Ranking Based
On Selection: 11
Clinical Pharmacology
Pharmacokinetics
Drug-Drug Interactions
Biologics
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
21
18
0.857
* Total H Index Rankings
Ranking Based
On Selection: 12
Diabetes
Obesity
Metabolism
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
21
13
0.619
* Total H Index Rankings
Ranking Based
On Selection: 13
Bone Metastasis
Cancer
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
20
17
0.850
* Total H Index Rankings
Ranking Based
On Selection: 14
Host Microbial relationships
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
20
16
0.800
* Total H Index Rankings
Ranking Based
On Selection: 15
Bioanalysis
LC-MS
Biotherapeutics
Biomarker
GLP
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
19
12
0.632
* Total H Index Rankings
Ranking Based
On Selection: 16
Neurobiology
Neurodegeneration
Multiple Sclerosis
Progression
Alzheimer's Disease
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
18
11
0.611
* Total H Index Rankings
Ranking Based
On Selection: 17
NMR
MRS
MRI
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
17
10
0.588
* Total H Index Rankings
Ranking Based
On Selection: 18
Precision Medicine
Clinical AI/ML
Digital Health Technology
Clinical Research
Biomarkers
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
16
16
1.000
* Total H Index Rankings
Ranking Based
On Selection: 19
drug discovery
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
16
10
0.625
* Total H Index Rankings
Ranking Based
On Selection: 20
immuno-oncology
cancer biology
stress response pathways
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
15
11
0.733
* Total H Index Rankings
Ranking Based
On Selection: 21
Muscle Biology
Metabolism
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
14
14
1.000
* Total H Index Rankings
Ranking Based
On Selection: 22
Acute kidney injury
Chronic kidney disease
diabetic nephropathy
renal fibrosis
glomerulopathies
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
14
12
0.857
* Total H Index Rankings
Ranking Based
On Selection: 23
Drug Discovery
Disease Susceptibility
Genetics
Toxicology
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
14
12
0.857
* Total H Index Rankings
Ranking Based
On Selection: 24
Human disease and therapeutics
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
14
10
0.714
* Total H Index Rankings
Ranking Based
On Selection: 25
Pharmacoepidemiology
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
13
8
0.615
David J Lederer
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
69
51
0.739
Respiratory drug development
clinical trials
Manuel AR Ferreira
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
66
50
0.758
Aris Baras
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
58
54
0.931
biotechnology
genetics
clinical trials
John D Davis
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
34
24
0.706
clinical pharmacology
monoclonal antibodies
drug-drug interactions
pharmacokinetics/pharmacodynamics
Wenhui Wei
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
33
22
0.667
Sai Kiran Sharma
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
27
20
0.741
Molecular Imaging
Antibody-based therapeutics
immunoPET
Targeted Radiotherapy
Cancer Biology
Benjamin Ortiz
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
26
23
0.885
asthma
urticaria
pediatrics
nasal polyps
food allergy
Nidal Al-Huniti
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
25
18
0.720
Quantitative Clinical Pharmacology
Clinical Pharmacometrics
Statistics
Drug Development
Clinical
Song Nie
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
23
16
0.696
Biotherapeutic Protein/AAV Characterization
LC-MS/MS
Bottom-Up Proteomics
Target Proteomics
Marcus Paul Kelly
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
23
15
0.652
Anti-cancer antibodies and cancer immunotherapy
Matthew P Kosloski
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
21
18
0.857
Clinical Pharmacology
Pharmacokinetics
Drug-Drug Interactions
Biologics
Jason Mastaitis
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
21
13
0.619
Diabetes
Obesity
Metabolism
Kalyan C Nannuru
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
20
17
0.850
Bone Metastasis
Cancer
Richard Copin
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
20
16
0.800
Host Microbial relationships
Marc Cao
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
19
12
0.632
Bioanalysis
LC-MS
Biotherapeutics
Biomarker
GLP
Jeffery Haines
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
18
11
0.611
Neurobiology
Neurodegeneration
Multiple Sclerosis
Progression
Alzheimer's Disease
Prodromos Parasoglou
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
17
10
0.588
Matthew F Wipperman
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
16
16
1.000
Precision Medicine
Clinical AI/ML
Digital Health Technology
Clinical Research
Biomarkers
Bo Chen
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
16
10
0.625
Nikos Kourtis
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
15
11
0.733
immuno-oncology
cancer biology
stress response pathways
Patrick J Ferrara
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
14
14
1.000
Muscle Biology
Metabolism
Kishor Devalaraja-Narashimha
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
14
12
0.857
Acute kidney injury
Chronic kidney disease
diabetic nephropathy
renal fibrosis
glomerulopathies
Peter Dornbos
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
14
12
0.857
Drug Discovery
Disease Susceptibility
Genetics
Toxicology
Ilias Stratikopoulos
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
14
10
0.714
Human disease and therapeutics
Rachel Sobel
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
13
8
0.615